First insight into the whole-genome sequence variations in Mycobacterium bovis BCG-1 (Russia) vaccine seed lots and their progeny clinical isolates from children with BCG-induced adverse events

Table 2 Characteristics of patients and M. bovis BCG-1 (Russia) clinical isolates

Patient ID/sex^a	Date of birth^b	Region of birth	Vaccination	Vaccine lot number used for inoculation	Vaccine manufacturer	Vaccine seed lot	Diagnosis^c	Age of surgical intervention^d	Date of surgical intervention^h	Clinical isolate	NCBI SRA accession No
1/f	05/2017	St. Petersburg	delayed ^e	411	Medgamal ^f	368 “shch”	A18.2	7 m	01/2018	577	SRR9593177
2/m	06/2016	Dagestan	at birth	537	Microgen ^g	368 “shch”	A18.0	1y8m	02/2018	1032	SRR9593172
3/m	07/2006	Moscow	at birth	621	Medgamal	361 “sh”	A18.0	9 m	04/2007	1986	SRR9593171
4/f	03/2002	St. Petersburg	at birth	281	Medgamal	361 “sh”	A18.0	14y	04/2016	2925	SRR9593170
5/f	07/2004	Ekaterinburg	at birth	25	Microgen	367 “sh”	A18.0	2y10m	05/2007	3363	SRR9593169
6/f	12/2004	St. Petersburg	at birth	437	Medgamal	361 “sh”	A18.0	2y6m	06/2007	4159	SRR9593168
7/m	04/2006	St. Petersburg	at birth	615	Medgamal	361 “sh”	A18.0	1y5m	09/2007	5075	SRR9593175
8/m	12/2004	St. Petersburg	at birth	725	Medgamal	361 “sh”	A18.0	4y9 m	09/2009	5340	SRR9593174
9/m	06/2005	Kabardino-Balkaria	at birth	567	Medgamal	361 “sh”	A18.0	1y3m	09/2006	5448	SRR9593173

^af female, m male; ^bmonth/year; ^cdiagnosis according to International Statistical Classification of Diseases and Related Health Problems (ICD-10): Tuberculosis of bones and joints (A18.0), A18.2 (Tuberculosis peripheral lymphadenopathy) [International statistical classification of diseases and related health problems. - 10th revision, edition 2010]; ^dy year, m month; ^edelayed for 4 months due to respiratory infection; ^fBranch “Medgamal,” Federal State Budgetary Institution “National Research Center for Epidemiology and Microbiology named after Honorary Academician N.F. Gamalei”, Ministry of Health of the Russian Federation, Russia; ^gScientific and Production Association for Immunobiological Preparations “Microgen,” Russia; ^hmonth/year

ISSN: 1471-2164